| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $203K | -81.5% |
| SG&A Expense | $3.0M | -73.0% |
| Operating Income | -$3.2M | +73.7% |
| Income Tax | $0 | — |
| Net Income | -$3.2M | +73.7% |
| EPS (Basic) | $0.00 | +100.0% |
| EPS (Diluted) | $0.00 | +100.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $3.7M | -23.9% |
| Current Assets | $3.7M | -23.9% |
| Total Assets | $3.7M | -23.8% |
| Current Liabilities | $10K | — |
| Stockholders' Equity | $217K | -84.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.2M | +36.2% |
| Financing Cash Flow | $1K | +0.0% |